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Shortening of Titin’s Elastic Tandem Ig Segment Leads to Cardiac Hyper-
trophy and Diastolic Dysfunction
Charles S. Chung1,2, Kirk R. Hutchinson1, Mei Methawasin1,
Chandra Saripalli1, John E. Smith1, Carlos G. Hidalgo1, Xiuju Luo1,
Siegfried Labeit3, Caiying Guo4, Henk L. Granzier1.
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Diastolic dysfunction is a poorly understood but clinically pervasive syn-
drome. Titin is the main determinant of cellular passive stiffness. However,
the physiological role that titin’s tandem Ig segment plays in stiffness gener-
ation and whether shortening this segment is sufficient to cause diastolic
dysfunction needs to be established by performing studies at a wide range
of organizational levels (skinned cells to the in vivo LV chamber). We pro-
duced a novel KO model by deleting nine immunoglobulin(Ig)-like domains
from the proximal tandem Ig segment (Ig 3-11) of titin’s spring region (IG
KO). Exon microarray analysis revealed no adaptations in titin splicing, while
novel phospho-specific antibodies did not detect changes in titin phosphory-
lation. Passive myocyte stiffness was increased in the KO and immunoelec-
tron microscopy revealed increased extension of the remaining titin spring
segments as the likely underlying mechanism. Diastolic stiffness was
increased at the tissue and organ levels; myocardial stiffness studies did not
detect changes in extracellular matrix based passive stiffness, supporting
a titin-based mechanism. IG KO mice have a reduced exercise tolerance
and develop LV hypertrophy that is associated with a marked increase in ex-
pression of hypertrophy-associated four and a half LIM proteins (FHL). These
findings suggest that titin-based stiffness plays a role in diastolic dysfunction
and hypertrophic signaling and that increased titin-based passive stiffness is
sufficient to cause diastolic dysfunction with exercise intolerance and LV
hypertrophy.
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Titin Mediates Sarcomere Length Dependence of Myocyte Power
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According to the Frank-Starling relationship, ventricular pressure increases
with end-diastolic volume. This is controlled, in large part, by sarcomere length
(SL) dependence of cardiac myofibrillar force, loaded shortening, and power.
Consistent with this, both myofibrillar force and power fall at shorter SL, how-
ever, when Ca2þ activated force and presumably thin filament activation levels
are matched between short and long SL (by increasing the activator [Ca2þ])
short SL actually yields faster loaded shortening and greater peak normalized
power output (PNPO). A potential mechanism for faster loaded shortening at
short SL is that as SL decreases titin becomes less taut which reduces the im-
pedance of cross-bridges, a process that may be mediated by titin’s interactions
with the thick filament. We propose a more slackened titin yields greater
myosin head radial and azimuthal mobility and these flexible cross-bridges
are more likely to maintain thin filament activation, which would allow more
force-generating cross-bridges to work against a fixed load resulting in faster
loaded shortening. We tested this idea by measuring SL dependence of power
at matched forces in rat skinned cardiac myocytes containing either N2B titin or
a longer, more compliant N2BA titin. We predicted less overshoot in power by
short SL in N2BA titin myocytes. Consistent with this, peak power did not
overshoot but was actually less at short versus long SL at matched thin filament
activation levels in N2BA-containing myocytes (Wt: DPNPO = þ0.0121 5
0.0115 (n=5), N2BA titin: DPNPO =0.05665 0.0493 (n=5)). These findings
are consistent with SL per se modulating the mechanical properties of cross-
bridges with this modulation being mediated by titin. This myofibrillar mech-
anism may help sustain ventricular power during periods of low preloads, and
perhaps a breakdown of this mechanism is involved in impaired function of
failing hearts.
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To understand the functional significance of phosphorylation that takes place in
the M domain of cMyBP-C, chemically skinned papillary muscle fibers of
transgenic mice were studied by sinusoidal length alterations and concomitant
tension transients. Muscle fibers were maximally activated at pCa 4.55 in thesolution that mimic physiological conditions (5 mM MgATP, 8 mM Pi,
200 mM total ionic strength with K-acetate) in myocytes. WT mice possess
phosphorylation sites S273, S282, and S302. SAS is a single mutant
S282A, and ADA and DAD are triple mutants S273A/S282D/S302A and
S273D/S282A/S302D, respectively. D models for phosphorylation (phospho-
mimetic), and A models for non-phosphorylation (phosphor-ablation). Isomet-
ric tension and stiffness of DAD were respectively ~0.5x of those of WT, but
tension and stiffness of t/t (cMyBP-C null), ADA, and SAS were respectively
similar to WT. The fast rate constant 2pc of DAD and t/t was ~0.6x of WT,
but that of ADA and SAS was similar to WT. The intermediate rate constant
2pb of DAD and SAS was ~1.3x of WT, but that of ADA and t/t was
similar to WT. These results demonstrate that cMyBP-C M domain phosphor-
ylation affects the cross-bridge kinetics at ATP binding and phosphate
release steps, indicating that phosphorylation affects myosin structure and
its interaction with actin. However, pCa-tension and pCa-stiffness studies
demonstrated that pCa50 (Ca
2þ sensitivity) and nH (cooperativity) were
respectively not different among mutants and WT groups, indicating that
phosphorylation of cMyBP-C has a minimal effect on the regulatory system.
The decreased amount of isometric tension only in DAD indicates that phos-
phorylation of S273 and S302 are most significant and they diminish the force
generation capability, presumably owing to the extra electrostatic interaction of
the M domain of cMyBP-C with actin thin filament, which may serve as
a break.
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Cardiac myosin binding protein-C (cMyBP-C) modulates contractility in part
through phosphorylation of serines (S) found in the cardiac-specific motif be-
tween domains C1 and C2. S282 phosphorylation appears to allow the hierar-
chical phosphorylation of S302 and S307 by protein kinase-A (PKA). We
investigated whether S282 phosphorylation status influenced the effects of
PKA on acto-myosin cross-bridge MgADP release rate (k-ADP) and MgATP
binding rate (kþATP) in myocardial strips. Transgenic mice expressing
cMyBP-C with a single amino acid switch at S282 to glutamic acid (D) or al-
anine (A) were generated to mimic phosphorylated or unphosphorylated states,
respectively. Mice were fed L-thyroxin for 10 days to ensure similar (>90%)
a-myosin heavy chain (a-MyHC) background. Skinned papillary muscles
were pretreated with alkaline phosphatase to reduce any differential in vivo
phosphorylation, and examined by length perturbation analysis at maximum
calcium activation (pCa 4.8) as MgATP concentration varied (0 to 5 mM).
a-MyHC k-ADP and kþADP increased 90% (212522 vs. 11159 s
1) and 45%
(867593 vs. 595550 mM1 s1) for S282D vs. S282A, demonstrating that
cMyBP-C S282 phosphorylation status significantly affects a-MyHC kinetics.
Following PKA treatment, k-ADP and kþADP values did not differ between
S282D and S282A, due to PKA reducing k-ADP by 23% (163519 s
1) and
kþATP by 45% (475535 mM
1 s1) for S282D, but increasing k-ADP by 23%
(13759 s1) and decreasing kþATP by 23% (457552 mM
1 s1) for S282A.
These results suggest that S282 phosphorylation most significantly affects
the initial functional status of the myocardium, prior to PKA-mediated effects
from cMyBP-C or other phosphorylatable myofilament proteins.
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Myosin binding protein-C (MyBPC) has been known for over thirty years to
inhibit actomyosin ATP hydrolysis and more recently has been shown to affect
the calcium sensitivity of force in muscle fibers. The various domains of
MyBPC have previously been shown to have complex interactions with other
myofibrillar proteins. The C-terminal domains have been shown to bind to
the thick filament and the N-terminal domains interact with the S2 region of
myosin and with f-actin. The number of mutations in cardiac MyBPC
(cMyBPC) are the second most prevalent of sarcomeric proteins in producing
cardiomyopathies. We have used steady state kinetics to study the molecular
mechanism by which the soluble N-terminal C0C1, C1C2 and C0C2 domains
of mouse and human cMyBPC affect the activation of myosin ATP hydrolysis
by f-actin and native porcine thin filaments.
Sunday, February 3, 2013 159aThe N-terminal domains of cMyBPC inhibit the activation of the steady state
ATPase myosin by f-actin. However, in the presence of native cardiac thin fil-
aments.the N-terminal domains C1C2 and C0C2 of mouse and human cMyBPC
produce biphasic effects on the steady state ATP hydrolysis of cardiac myosin-
S1. That is, ATPase is activated at low ratios of cMyBPC-N-terminal domain to
thin filament and is inhibited by higher ratios similar to the effects observed
with f-actin. These data suggest that low ratios of cMyBPC N-terminal domains
activate thin filaments in a mechanism similar to that of rigor myosin-S1 but
higher ratios inhibit the ATPase rate by competing with myosin-S1-ADP-Pi
binding to actin and thin filaments. Effects also appear species-dependent since
the C0C1 domains of human cMyBPC produce similar effects as C1C2 and
C0C2 on ATPase in the presence of thin filaments, but mouse C0C1 does
not produce significant activation.Cellular Pathways & Networks
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Meclofenamate Sodium, a Non-Steroidal Anti-Inflammatory Drug,
Directly Interacts with the Proteasome and Causes Cell Death in H9c2
Cardiac Cells
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In the United States, 30 billion dosages of non-steroidal anti-inflammatory
drugs (NSAIDs) are consumed annually to relieve fever, pain, and inflamma-
tion. While NSAIDs are generally considered safe, some including meclofena-
mate sodium (MS) have been reported to increase the risk of cardiovascular
events. Because the impairment of the proteasome, a multi-catalytic complex
that breaks down 60-80% of proteins in the mammalian cell, has been associ-
ated with heart failure, the effects of MS on the proteasome activity were inves-
tigated. MS at 30 micromolar inhibited purified 20S proteasome activity by
40% and 26S proteasome activity in H9c2 rat cardiac cells and mouse heart tis-
sue lysates by 30-40%. MS was also shown to decrease the cell proliferation
rate and muscle differentiation of H9c2 cells. To investigate the mechanism
of action of MS, H9c2 cells were treated with MS and the fluorescent protea-
some inhibitor MV151 that bind to beta 1, beta 2, and beta 5 enzymatic sites
of the proteasome. MS, in a concentration-dependent manner, competed with
MV151, indicating that MS may exert its inhibitory effects by directly binding
to the proteasome’s active sites. At the mRNA level, 100 micromolar MS
increased the expression of genes involved in stress response and antioxidant
metabolism, such as glutathione S-transferase omega. When H9c2 cells were
pre-treated with 3 millimolar tempol, a membrane-permeable radical scaven-
ger, then with 200 micromolar MS for 24hr, tempol recovered the beta 5 26S
proteasome activity by 20-40%. However, tempol and other antioxidants
such as N-acetyl cysteine and L-ascorbic acid (vitamin C) alone inhibited the
proteasome activity by 20-50%. MS does not increase the caspase-3 activity
at 10-30 micromolar concentrations, suggesting that apoptosis is not involved
in the decreased cell viability in MS treated H9c2 cells.
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Spinal muscular atrophy (SMA) - the most common genetic cause of death in
infancy - is a motor neuron disease caused by reduced expression of the sur-
vival motor neuron (SMN) protein. It is currently unknown why reduction in
SMN, leads to selective motor deficits and muscle weakness. Using the
SMA-D7 mouse model, we have previously reported that the sensory-motor
circuit is dysfunctional early in the disease and precedes any motor neuron
loss. Motor neurons in the L1 segment, innervating proximal muscles, are
abnormally hyperexcitable and more affected than L5 motor neurons, innervat-
ing distal hindlimbs early after birth. To test whether this hyperexcitability is
either due to synaptic dysfunction or SMN deficiency per se in motor neurons,
we recorded intracellularly from L5 motor neurons at a time (P4) when there
was no significant functional synaptic impairment.
We employed the in vitro intact spinal cord preparation. Whole-cell patch
clamp recordings revealed that the intrinsic properties of SMA L5 motor neu-
rons were not significantly different than wild type (WT) age-matched counter-
parts. The passive membrane property of input resistance was on average
72.7518.1 MU in WT (n=10) and 53.9521.7 MU in SMA (n=5) motor
neurons. Similarly, the time constant was 1.950.5 ms in WT and 2.0 5
0.7 ms in SMA. Furthermore, the active membrane properties of: Rheobase
(WT: 0.750.2 nA; SMA:0.850.2 nA), Vthreshold (WT: 31.653.7 mV;SMA: 33.652.6 mV), action potential amplitude (WT: 72.855.2 mV;
SMA: 73.253.6 mV) and rate of rise (WT: 48.856.2 mV/ms; SMA:
40.2510.0 mV/ms) were not significantly different (t-test).
These results indicate that the intrinsic hyperexcitability of SMA motor neu-
rons stems from dysfunctional spinal circuits and raise the possibility that
SMA may be a disease of motor circuits acting via non-cell autonomous
mechanisms.
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In type 2 diabetes (T2DM), hyperglycemia (HG) and increased sympathetic
drive may alter mitochondria energetic/redox properties, decreasing the organ-
elle’s functionality. These perturbations sustain basal low-cardiac performance
and limited exercise capacity. We have recently reported that improving the re-
dox/energetic balance of T2DM (db/db) murine cardiomyocytes/hearts with
GSH or palmitate (Palm) preserves contractile performance under high-
energy demand imposed by combined HG and b-adrenergic stimulation. To
further understanding the metabolic basis of Palm salutary action, we first ap-
plied metabolomics to Langendorff-perfused T2DMmurine hearts subjected to
energy/redox stress conditions. In the absence of Palm, HG activates polyol
pathways (sorbitol, glycerol, xylitol) triggering flux limitations in glycolytic
and pentose phosphate (PP) pathways. The metabolite profile under Palm
reveals that this fatty acid (FA) reverses the detrimental action of HG by de-
creasing polyol accumulation and increasing flux through PP, glycolytic, and
beta-oxidation pathways, with a concomitant improvement in cardiomyocyte
contraction. To confirm this observation, next we inhibited the polyol or acti-
vated the PP pathways. Preincubating HGþISO-treated myocytes with the
aldose reductase inhibitor Zopolrestat (1mM) improved the adrenergic inotropic
response, in parallel with the re-activation of glycolysis and oxidative phos-
phorylation. These same effects were observed pre-incubating HGþISO chal-
lenged myocytes with the activator of transketolase benfotiamine (50mM).
Present data indicate that in T2DM hearts HG/ISO regimen unveils a status
of mitochondrial dysfunction that favors adverse intracellular redox/energetic
conditions and a metabolic remodeling that implies a glucose shunt to polyol
pathways and an apparent blockade of glycolysis. These changes appear to
be relieved by the exogenous administration of the FA Palm.
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Many cellular networks rely on the regulated transport of their components to
transduce extracellular information into precise intracellular signals. The dy-
namics of these networks is typically described in terms of compartmentalized
chemical reactions. There are many important situations, however, in which the
properties of the compartments change continuously in a way that cannot nat-
urally be described by chemical reactions. Here, we develop an approach based
on transport along a trafficking coordinate to precisely describe these processes
and we apply it explicitly to the TGF-b signal transduction network, which
plays a fundamental role in many diseases and cellular processes. The results
of this newly introduced approach accurately capture the distinct TGF-b signal-
ing dynamics of cells with and without cancerous backgrounds and provide an
avenue to predict the effects of chemical perturbations in a way that closely re-
capitulates the observed cellular behavior.
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Multistability in biological systems is an important concept that is believed to
underlie phenotypic diversity in microorganisms as well as tissue differentia-
tion at the multicellular level. Despite the importance of the subject, under-
standing of this phenomenon derives from a very small group of extensively
studied examples. We are working to identify novel biological networks that
exhibit bistability in nutrient uptake. In particular, we are investigating uptake
